Shining a Light on
Microbiome Drug Development Success

Uniting Leaders to Optimize Clinical Outcomes and Transform Patient Care

A private network for Microbiome drug developers

Designed by Microbiome drug developers

At a time when milestone regulatory approvals are shaping the microbiome-based therapeutic landscape and with more companies entering the clinic, now is the time to gain momentum and succeed as a whole industry to drive awareness of the microbiome in human health.

We need to build confidence in investors, understand the regulatory environment, and demonstrate the potential of microbiome-based therapeutics in other disease indications beyond the gut.

To address some of these challenges head-on, microbiome pioneers worldwide have created the Microbiome Drug Development Searchlight network The networks sole purpose is to optimize positive clinical outcomes to accelerate safe, effective and approved microbiome-based therapeutics to patients.

The network fosters pre-competitive experience sharing and value exchange. By joining, you can benefit from this networks’ innovative thinking, avoid making the same mistakes as others, capitalise on best practices, and accelerate the delivery of safe, effective, and approved microbiome-based therapeutics to patients.

The required clinical efficacy outcome for microbiome products vs classical therapeutics
Building investor confidence in microbiome drug development
More clarity on the regulatory process for LBPs and harmonizing global regulatory affairs

Business critical conversations

Virtual cornerstone meetings

We facilitate, structured, discussion-driven, Microbiome-focused quarterly meetings for member companies.

Each high-impact 90-minute meeting takes place virtually via Zoom. The meeting agenda is carefully curated and focused on the topics and critical challenges requested by Searchlight members.

Member companies are represented by one internal champion with strategic oversight over its microbiome program to ensure that each discussion is high-value, high-impact, and delivers tangible outputs for members to take back to their organization. 

Innovation doesn’t happen in isolation

Searchlight makes meaningful progress

“As leaders in the microbiome field with the goal to develop both safe and efficacious LBP drugs to meet the unmet needs of patients; we are all simultaneously facing our challenges. The most logical way to bring LBPs to market at an efficient pace is to share our experiences and knowledge while maintaining our Intellectual Property, that will accelerate benefits to the patient. And this is the opportunity I see that the Searchlight network will provide.”

“We can support one another in making meaningful progress by exchanging knowledge and offering guidance based on our own experiences. Being part of this Microbiome Drug Development Searchlight network means that we are more than willing to work collectively in this exciting and challenging fast-growing field.”

“My view is that the microbiome therapeutics sector is at a critical juncture as first-generation donor derived programs move into the clinical and cell bank derived consortia and single strain products move further down clinic translation. To help the sector address these challenges we require a central forum that can focus on the technical aspects of regulatory, CMC and clinical development. This searchlight network has the potential to be that essential forum for the microbiome industry”

Network with the best in the field

Searchlight makes meaningful progress

Sahar El Aidy

Sahar El Aidy
Associate Professor and Chair of Host-Microbe Metabolic Interactions
University of Groningen 

Laura Cox

Laura Cox
Assistant Professor in the Department of Neurology
Ann Romney Center for Neurologic Diseases at Harvard Medical School and BWH Hospital

ESonia Timberlakevren Alici, Co-Director of next generation NK cell competence center, Karolinska Institutet

Sonia Timberlake
Independent Consultant

Searchlight - LEAP HR - Exec Summary lock up

Membership brochure

For more information on what’s included as part of the Microbiome Drug Development: Searchlight membership, please download the membership brochure. 

Here’s what you’ll learn more about: 

  • The unique mission and purpose of the network 
  • What membership includes 
  • How the quarterly cornerstone meetings work 
  • How bespoke value delivery works 
  • How we deliver demonstrable value to you 
  • Annual member investment 

The Searchlight platform

Build meaningful relationships and gain value all year around

Microbiome Searchlight - App animation - (400 × 400 px)

Instant messaging

Contact fellow members via the private or group chat features.

Member meetups

Come together with leaders throughout the community at virtual cornerstone meetings and in-person gatherings at Hanson Wade conferences.

On demand

Explore the library of business critical content and videos on demand via the thematic rooms and content channels.

Apply today to join the Microbiome network

Tap into a ready-made collaborative working group to solve common challenges together